Determine
Man looking at a laptop.

DETERMINE news hub

Discover our latest updates, including our progress, site openings, and partnership initiatives.

Interested in learning more about the trial and how to get involved?

Find out more about DETERMINE

Our highlights

DETERMINE team recieving an award.

The timelines to treating the 100th patient

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much-needed treatment options for people with rare cancers, including treating its 100th patient.

Read about DETERMINE's successes

DETERMINE logo.

Patient finds hope with DETERMINE trial

Sky News covered the Target National genetic screening trial and spoke to Pamela Garner-Jones who was diagnosed with cervical cancer in 2021. Through TARGET National, Pamela was matched to a treatment on our DETERMINE trial and has since seen her tumour shrink by two thirds and symptoms improve.

Read about the patient's story

Read about the trial

The PRIME-ROSE logo icon.

Precision cancer medicine collaboration in Europe

PCM4EU (Personalized Cancer Medicine for all EU citizens) and PRIME-ROSE (Precision Cancer Medicine Repurposing System Using Pragmatic Clinical Trials) aim to facilitate implementation of precision cancer medicine in Europe.

Read about the collaboration

Explore the PRIME-ROSE website

In other news

2023

2022

2021